arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Arbutus Biopharma Corp

ABUS

$4.62 ▲ +0.08 (+1.76%) at close

16 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Arbutus Biopharma Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $885.2M

Dividend Yield —

Revenue Growth 128.2% ↗

Op. Margin -271.0%

ROIC -39.4% ↗

FCF / Share $-0.21 ↗

Trailing P/E —

Price / Book 11.6x

FCF Yield —

Debt / Equity 0.00

info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$14.08M

↑ +128.2% —

Net Income Profit after all expenses

$-33.50M

↑ +52.1% —

Operating Margin Operating profit as % of sales

-271.0%

↑ +37.1% 0th

FCF / Share Free cash flow per share

$-0.21

↑ +41.0% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns →

Financial Health

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	128.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1503%)	-66.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-925%)	-53.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-769%)	255.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3089%)	58.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+637%)	15.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+88%)	1.1% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-86%)	-44.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-655%)	617.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7620%)	-94.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1275%)	66.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+729%)	-3.3% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-141%)	9.6% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21%)	-16.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-301%)	—	—
EPS Growth YoY (%)	55.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.6% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	4.3% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	44.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	17.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	78.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-440.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-95.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—
Net Income Growth YoY (%)	52.1% Excellent ↑ Excellent Improving Year-over-year change in net income	4.0% Caution ↑ Caution Improving Year-over-year change in net income	-4.9% Weak ↓ Weak Declining Year-over-year change in net income	8.9% Fair ↑ Fair Improving Year-over-year change in net income	-19.6% Weak ↑ Weak Improving Year-over-year change in net income	58.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-169.4% Weak ↓ Weak Declining Year-over-year change in net income	32.4% Excellent ↑ Excellent Improving Year-over-year change in net income	78.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-528.5% Weak ↓ Weak Declining Year-over-year change in net income	-57.4% Weak Weak Year-over-year change in net income	-176.2% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	41.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	33.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-120.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	63.1% Excellent Excellent Year-over-year change in free cash flow	5.6% Fair Fair Year-over-year change in free cash flow	—	—	—	12.4% Fair ↑ Fair Improving Year-over-year change in free cash flow	7.1% Fair ↑ Fair Improving Year-over-year change in free cash flow	-101.2% Weak Weak Year-over-year change in free cash flow	-27.9% Weak Weak Year-over-year change in free cash flow	N/M	N/M	—	—
Revenue CAGR 3Y (%)	-28.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-17.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	37.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	86.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-13.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	59.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-37.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-54.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	20.8% Excellent Excellent Compound annual revenue growth over 3 years	-3.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	15.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	0.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	25.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	29.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	49.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-22.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-16.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-17.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-5.4% Weak Weak Compound annual revenue growth over 5 years	-38.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	-271.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1906%)	—	-430.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2970%)	-167.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1218%)	—	—	—	—	—	—	-411.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2843%)	-223.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1591%)	-78.6% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-624%)	-91.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-712%)	-63.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-524%)	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	7.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-237.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2082%)	—	-401.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3446%)	-178.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1583%)	—	—	—	—	—	—	-245.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2148%)	-259.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2264%)	-90.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-858%)	—	-60.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-600%)	—
FCF Margin (%) (%)	-281.5% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	—	-479.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-91.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-229.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-90.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-48.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	233.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-46.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	-39.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-61.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-58.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-183.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-191.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-161.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-40.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-136.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-178.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-16.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-43.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-392%)	-71.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-579%)	-68.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-558%)	-50.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-45.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-400%)	-62.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-517%)	-211.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1509%)	-28.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-46.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-408%)	-189.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1362%)	-11.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-44.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-394%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	72.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+382%)	-192.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1386%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Debt to Equity (x)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	-170.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-37.92x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-25.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-68.35x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-397.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-425.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-18.01M	$-36.33M	$-26.29M	$-30.78M	$-109.28M	$-52.25M	$-31.80M	$-36.94M	$-54.29M	$-23.41M	$-166.78M	$-72.19M	$-68.72M	$-47.02M	$-9.03M	$-12.41M
Debt / EBITDA (x)	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$0.07	$0.03	$0.11	$0.26	$0.10	$0.09	—	—	$0.20	$0.03	$0.55	$0.69	$1.01	$1.03	$1.49	—
Basic EPS, GAAP (USD)	$-0.17	$-0.38	$-0.44	$-0.46	$-0.83	$-1.00	—	—	$-1.56	$-7.24	$-1.34	$-1.80	$-0.92	$2.16	$-0.89	—
Free Cash Flow per Share (USD)	$-0.21	$-0.35	$-0.52	$-0.24	$-0.64	$-0.68	—	—	$-1.02	$-1.17	$-1.26	$-0.62	$-0.49	$2.40	$-0.70	—
Book Value per Share (USD)	$0.40	$0.51	$0.62	$0.87	$1.17	$1.14	$1.12	$3.61	$3.31	$3.70	$10.04	$3.92	$3.11	$2.86	$0.46	—
Tangible Book Value per Share (USD)	$0.40	$0.51	$0.62	$0.87	$1.17	$1.14	$1.12	$2.41	$1.81	$1.44	$0.60	$3.92	$3.11	$2.86	$0.46	—
Basic Weighted Avg Shares (shares)	191.60M	185.61M	165.96M	150.94M	106.24M	75.84M	—	—	54.72M	53.07M	45.46M	21.60M	15.30M	13.73M	11.32M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Working Capital (USD)	$88.45M	$111.70M	$109.54M	$118.28M	$149.44M	$118.16M	$86.00M	$117.99M	$114.74M	$121.98M	$173.30M	$96.21M	$57.82M	—	—	—
LT Debt (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$76.58M	$97.37M	$106.02M	$136.85M	$169.44M	$101.97M	$72.74M	$200.23M	$182.47M	$203.00M	$547.68M	$88.03M	$59.19M	$40.92M	$5.23M	$10.79M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$14.08M	$6.17M	$18.14M	$39.02M	$10.99M	$6.91M	$6.01M	$5.95M	$10.70M	$1.49M	$24.87M	$14.95M	$15.46M	$14.11M	$16.81M	—
Depreciation Expense (USD)	$363.00K	$1.38M	$1.40M	$1.43M	$1.75M	$1.98M	$2.03M	$2.18M	$2.03M	$1.09M	$589.00K	$529.00K	$613.00K	$865.60K	$986.93K	—
Net Income, GAAP (USD)	$-33.50M	$-69.92M	$-72.85M	$-69.46M	$-76.25M	$-63.74M	$-153.72M	$-57.06M	$-84.41M	$-384.16M	$-61.12M	$-38.84M	$-14.06M	$29.61M	$-10.08M	—
Operating Cash Flow (USD)	$-39.64M	$-64.85M	$-85.94M	$-35.36M	$-67.53M	$-51.44M	$-71.01M	$-67.87M	$-48.64M	$-57.88M	$-54.78M	$-12.42M	$-6.74M	$32.91M	$-7.83M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 56 quarters

Arbutus Biopharma Corp

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ABUS with peers